Urogenital atrophy

descriptionPublicationkeyboard_double_arrow_right Article 01 Sep 2008 English Publisher:Informa UK LimitedJournal:Menopause International, volume 14, pages 136-137 (issn: 1754-0453,

Copyright policy )

Authors: Joan, Pitkin; Margaret, Rees;

doi: 10.1258/mi.2008.008022

pmid: 18714081

Urogenital atrophy

- Summary
- Subjects
- Metrics

Abstract

The British Menopause Society Council aims to aid health professionals to inform and advise women about postreproductive health. This guidance refers to the long-term condition of urogenital atrophy. Treatment choice should be based on up to date information and targeted to individual women's needs. Non-estrogen and estrogen-based treatments are discussed.

Related Organizations

University of Oxford
United Kingdom

Keywords

Health Knowledge, Attitudes, Practice, Urogenital System, Professional-Patient Relations, Female Urogenital Diseases, United Kingdom, Patient Education as Topic, Humans, Women's Health, Female, Atrophy, Menopause

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	7
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%